scholarly journals Reply to ‘Highly selective A3 adenosine receptor agonists relieve chronic neuropathic pain’

2017 ◽  
Vol 27 (8) ◽  
pp. 969-969
Author(s):  
Rodolfo Couto Maia
Keyword(s):  
Neuropathic Pain ◽  
Adenosine Receptor ◽  
Chronic Neuropathic Pain ◽  
Adenosine Receptor Agonists ◽  
Receptor Agonists ◽  
A3 Adenosine Receptor

Design, synthesis and evaluation of N6-substituted 2-aminoadenosine-5′-N-methylcarboxamides as A3 adenosine receptor agonists

MedChemComm ◽  
2014 ◽  
Vol 5 (2) ◽  
pp. 192-196 ◽  
Author(s):  
Shane M. Devine ◽  
Lauren T. May ◽  
Peter J. Scammells
Keyword(s):  
Adenosine Receptor ◽  
Design Synthesis ◽  
Adenosine Receptor Agonists ◽  
Receptor Agonists ◽  
A3 Adenosine Receptor

A series of N6-substituted 2-aminoadenosine-5′-N-methylcarboxamides were synthesized from the versatile intermediate, O6-(benzotriazol-1-yl)-2-amino-2′,3′-O-isopropylideneinosine-5′-N-methylcarboxamide (1) and evaluated as A3 adenosine receptor agonists.

N6-Ethyl-2-alkynyl NECAs, Selective Human A3 Adenosine Receptor Agonists.

ChemInform ◽  
2006 ◽  
Vol 37 (31) ◽  
Author(s):  
Ran Zhu ◽  
Cynthia R. Frazier ◽  
Joel Linden ◽  
Timothy L. Macdonald
Keyword(s):  
Adenosine Receptor ◽  
Adenosine Receptor Agonists ◽  
Receptor Agonists ◽  
A3 Adenosine Receptor

scholarly journals Resistance of Muscle to Tumor Metastases: A Role for A3 Adenosine Receptor Agonists

Neoplasia ◽  
2001 ◽  
Vol 3 (2) ◽  
pp. 125-131 ◽  
Author(s):  
Sara Bar-Yehuda ◽  
Faina Barer ◽  
Lea Volisson ◽  
Pnina Fishman
Keyword(s):  
Adenosine Receptor ◽  
Adenosine Receptor Agonists ◽  
Receptor Agonists ◽  
A3 Adenosine Receptor ◽  
Tumor Metastases
Sign in / Sign up

Export Citation Format

Share Document